CGCABLE
834639
KLT
831689
DAYU BIOLOGICAL
871970
Fujian Superpipe
300198
WuHan Hvsen Biotechnology
300871
(FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | 16.57%10.69B | -9.37%9.85B | -16.07%10.37B | -17.75%10.85B | -16.28%9.17B | 6.06%10.87B | -12.27%12.36B | -0.01%13.19B | -17.07%10.95B | -18.26%10.25B |
Transactional financial assets | 74.39%2.75B | 10.34%1.73B | 11.21%1.72B | 4.11%1.64B | -14.74%1.58B | 1.39%1.56B | -2.29%1.55B | 251.42%1.58B | 369.37%1.85B | 229.90%1.54B |
Notes receivable and accounts receivable | 33.62%2.66B | -16.35%2.96B | -8.92%2.28B | -2.38%2.31B | -0.55%1.99B | 159.35%3.53B | 91.66%2.51B | 96.95%2.36B | 14.48%2B | -53.73%1.36B |
-Notes receivable | -80.88%1.09M | -22.37%3.6M | -71.67%2.04M | -60.35%4.64M | -31.50%5.69M | -32.98%4.64M | 11.99%7.2M | 98.98%11.71M | -43.55%8.3M | 7.19%6.93M |
-Accounts receivable | 33.95%2.66B | -16.35%2.95B | -8.74%2.28B | -2.09%2.3B | -0.42%1.98B | 160.33%3.53B | 92.05%2.5B | 96.94%2.35B | 14.97%1.99B | -53.86%1.36B |
Other receivables (including interest and dividends) | -4.05%1.41B | 1.41%1.64B | 68.50%2.6B | -15.23%1.71B | -15.33%1.47B | -23.52%1.62B | -31.97%1.54B | -13.65%2.02B | -27.81%1.73B | 20.05%2.12B |
-Dividend receivable | 796.37%32.94M | --3.68M | -88.20%3.68M | -88.20%3.68M | -88.20%3.68M | --0 | -62.15%31.13M | -29.63%31.13M | -29.63%31.13M | 3.36%62.26M |
-Accrued interest receivable | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
-Other receivable | -6.06%1.38B | 1.18%1.64B | 71.72%2.6B | -14.09%1.71B | -14.00%1.46B | -21.20%1.62B | -30.84%1.51B | --1.99B | -27.77%1.7B | 20.64%2.05B |
Contractual assets | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Advance payment | 12.72%1.13B | 28.08%1.31B | 32.10%1.17B | 41.29%1.22B | 43.07%1B | -9.99%1.02B | -14.66%885.79M | -2.96%861.71M | -13.08%699.87M | 32.12%1.14B |
Inventories | -14.23%36.96B | -14.06%42.67B | -15.19%41.48B | -15.74%41.89B | -14.81%43.09B | -7.76%49.65B | -5.93%48.91B | -7.34%49.72B | -3.81%50.58B | 16.70%53.83B |
Receivable financing | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Assets held for sale | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Non-current assets due within one year | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Other current assets | -6.38%14.71B | 30.29%16.59B | 29.32%15.86B | 29.80%15.98B | 28.00%15.71B | 21.46%12.74B | 18.42%12.27B | 16.96%12.31B | 47.56%12.28B | 46.95%10.49B |
Total current assets | -4.78%70.72B | -5.36%77.06B | -5.64%75.76B | -7.86%75.81B | -7.46%74.27B | 0.45%81.43B | -3.06%80.29B | -0.01%82.27B | 0.91%80.26B | 12.55%81.06B |
Non Current assets | ||||||||||
Debt investment | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Other debt investment | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Other equity investment | 14.52%425.27M | -23.13%326M | -29.93%333.16M | -48.03%320.77M | -39.56%371.35M | -43.55%424.07M | -35.62%475.44M | -16.90%617.2M | -18.22%614.4M | 12.04%751.23M |
Other non-current financial assets | 276.49%331.15M | 587.38%219.6M | 865.36%131.89M | 544.43%88.12M | 537.12%87.96M | 132.78%31.95M | -5.15%13.66M | -98.26%13.67M | -98.25%13.81M | -97.71%13.72M |
Investment real estate | 1.13%23.38B | 3.44%23.54B | 3.16%23.47B | 5.18%23.27B | 4.03%23.12B | 2.04%22.76B | 2.29%22.75B | -0.33%22.12B | 0.47%22.22B | 4.75%22.3B |
Long-term equity investment | 4.93%15.57B | 4.28%14.61B | 3.73%14.63B | 8.85%14.84B | 10.53%14.84B | 10.29%14.01B | 9.49%14.1B | 8.51%13.63B | 7.35%13.42B | 1.01%12.7B |
Long term receivable account | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Fixed assets | -23.68%3.05B | ---- | -10.65%3.06B | ---- | 5.27%3.99B | ---- | -29.97%3.42B | ---- | -27.83%3.79B | ---- |
Fixed assets liquidation | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- |
Constru in process | -65.99%64.02M | ---- | 3.70%172.4M | ---- | -1.39%188.22M | ---- | -36.95%166.24M | ---- | -7.08%190.89M | ---- |
Construction materials | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- |
Productive biological assets | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Oil and gas assets | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Intangible assets | -15.14%1.32B | -9.02%1.35B | -18.93%1.23B | -14.15%1.64B | -30.67%1.55B | -57.72%1.48B | -56.98%1.52B | -46.92%1.91B | -39.03%2.24B | -5.81%3.51B |
Development expenditure | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Goodwill | -28.43%1.07B | -14.10%1.25B | -14.59%1.25B | -5.73%1.48B | -4.11%1.49B | -56.65%1.45B | -56.39%1.46B | -53.35%1.57B | -53.90%1.56B | -1.25%3.35B |
Long deferred expense | -21.40%295.71M | -12.00%319.86M | -8.78%317.56M | 2.80%344.92M | 6.59%376.2M | 21.54%363.47M | 25.15%348.12M | 20.25%335.51M | 25.93%352.95M | 11.00%299.05M |
Deferred tax assets | 10.87%3.37B | 9.97%3.34B | 10.43%3.32B | 4.53%3.13B | 2.76%3.04B | -17.61%3.04B | -17.51%3.01B | -12.79%3B | -10.93%2.96B | 33.64%3.69B |
Usufruct assets | 52.28%992.89M | -25.65%517.14M | -27.97%547.62M | -16.33%591.9M | -10.78%652M | -4.88%695.52M | 13.70%760.31M | 6.06%707.42M | 18.57%730.8M | 22.39%731.2M |
Other non current assets | 74.63%109.25M | -88.84%117.27M | -89.80%107.15M | -92.36%82.24M | -94.16%62.56M | 861.59%1.05B | 1,218.83%1.05B | 1,233.97%1.08B | 1,353.09%1.07B | 169.99%109.25M |
Total non current assets | 0.40%49.97B | 0.06%48.81B | -1.04%48.56B | 3.02%49.84B | 1.23%49.77B | -7.20%48.78B | -6.66%49.07B | -8.73%48.38B | -7.17%49.17B | 2.33%52.57B |
Total assets | -2.70%120.69B | -3.33%125.87B | -3.90%124.32B | -3.83%125.65B | -4.16%124.04B | -2.56%130.21B | -4.46%129.36B | -3.43%130.65B | -2.32%129.43B | 8.30%133.63B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | -14.13%8.7B | 0.86%9.14B | 15.92%10.56B | 45.17%10.85B | 48.19%10.13B | 21.17%9.06B | 19.43%9.11B | 7.24%7.47B | 10.86%6.84B | 11.50%7.48B |
Transactional financial liabilities | 15.65%6.62B | 20.05%6.58B | 45.11%6.29B | 29.83%5.74B | 68.61%5.73B | 5.01%5.49B | -8.37%4.34B | 11.99%4.42B | -16.75%3.4B | 32.08%5.22B |
Notes payable and accounts payable | -6.86%9.44B | -0.38%9.04B | 17.67%9.69B | 30.29%11.01B | 21.63%10.14B | 16.54%9.07B | 4.49%8.24B | 2.89%8.45B | -9.55%8.33B | 15.65%7.79B |
-Notes payable | 21.31%1.11B | 165.27%1.43B | 239.99%1.43B | 9,564.25%2.11B | 1,435.45%912.27M | 3,223.61%538.53M | 2,035.64%419.17M | -21.93%21.85M | 149.52%59.41M | -11.81%16.2M |
-Accounts payable | -9.65%8.33B | -10.83%7.61B | 5.75%8.27B | 5.57%8.9B | 11.48%9.22B | 9.85%8.54B | -0.58%7.82B | 2.97%8.43B | -9.96%8.27B | 15.72%7.77B |
Contract liabilities | -34.88%4.91B | -37.30%9.67B | -54.68%6.5B | -53.96%6.35B | -38.47%7.54B | 45.80%15.43B | 55.82%14.34B | 33.28%13.8B | 33.06%12.26B | 27.79%10.58B |
Short term bonds payable | 43.35%1.83B | 32.39%1.51B | 178.89%1.48B | --2.14B | --1.27B | -63.79%1.14B | -82.95%530.95M | ---- | --0 | 213.26%3.15B |
Advance receipts | -3.76%90.95M | 95.08%127.46M | 44.83%104.21M | 36.49%80.86M | 108.86%94.5M | 16.09%65.34M | 34.79%71.95M | 59.76%59.24M | -27.31%45.25M | -39.14%56.28M |
Salaries payable | -16.70%482.31M | -22.81%218.43M | -32.33%219.67M | -17.55%294.43M | -21.30%578.98M | 54.60%282.98M | 18.02%324.62M | 37.74%357.09M | -0.63%735.68M | -20.76%183.04M |
Taxs payable | 4.38%7.48B | 0.52%7.08B | -0.57%7.32B | -2.06%7.05B | -6.86%7.17B | 2.13%7.04B | 4.93%7.36B | -10.34%7.19B | -8.40%7.69B | 17.70%6.89B |
Other payable (including interest and dividends) | 17.25%7.82B | 31.96%8.09B | 10.10%8.03B | 4.82%6.96B | 5.28%6.67B | 1.90%6.13B | 37.70%7.29B | 22.95%6.64B | -4.19%6.33B | -22.04%6.02B |
-Interest payable | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
-Dividend payable | -24.18%22.9M | 2.55%25.75M | -42.69%330.64M | 19.79%28.42M | 26.19%30.2M | 13.15%25.11M | 180.01%576.95M | -84.23%23.73M | -84.09%23.93M | -85.18%22.19M |
-Other payable | 17.44%7.79B | 32.08%8.06B | 14.64%7.7B | 4.76%6.93B | 5.20%6.64B | 1.86%6.1B | 31.93%6.72B | --6.62B | -2.33%6.31B | -20.79%5.99B |
Hold and for sell liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Non current liabilities due within one year | 2.33%9.24B | 2.12%9.41B | -21.49%8.66B | -24.25%9.76B | -31.15%9.03B | -22.37%9.21B | -19.28%11.03B | 14.53%12.88B | 53.36%13.11B | 20.03%11.87B |
Other current liabilities | 26.99%1.45B | -3.80%1.64B | -15.28%1.06B | -20.14%1B | 4.27%1.14B | 121.17%1.71B | 86.30%1.26B | 41.43%1.25B | 50.79%1.1B | 44.96%771.06M |
Total current liabilities | -2.39%58.06B | -3.15%62.59B | -6.20%59.92B | -2.07%61.23B | -0.59%59.48B | 7.70%64.63B | 7.31%63.89B | 5.29%62.53B | 7.66%59.84B | 17.65%60.01B |
Current liabilities | ||||||||||
Long term loan | -14.77%16.14B | -16.66%16.63B | -8.36%18.34B | -20.52%18.43B | -20.28%18.94B | -20.62%19.95B | -24.32%20.02B | -3.99%23.18B | 2.80%23.76B | 17.09%25.14B |
Bonds payable | 590.21%1.39B | -23.79%940M | --0 | --0 | -87.41%200.9M | -43.30%1.23B | -63.42%1.23B | -82.87%800.9M | -77.28%1.6B | -63.74%2.18B |
Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Perpetual Debt | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Long term account payable | ---- | ---- | --2.3B | ---- | ---- | ---- | ---- | ---- | 1,425.51%78.57M | ---- |
Long term salaries pay | -88.14%879.84K | -92.73%530.51K | -92.88%531.08K | -7.20%7.06M | -52.27%7.42M | -20.64%7.3M | -47.30%7.45M | -47.60%7.61M | 4.75%15.54M | -59.41%9.2M |
Specific account payable | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Estimate liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Deferred tax liabilities | -3.90%3.17B | -0.64%3.25B | 0.70%3.31B | -6.16%3.26B | -7.18%3.3B | -6.75%3.27B | -6.38%3.29B | 1.50%3.47B | 3.21%3.56B | 6.00%3.51B |
Long term deferred income | -15.93%99.23M | -29.29%102.82M | -26.38%108.65M | -31.29%113.5M | -29.82%118.04M | 40.78%145.41M | 42.08%147.58M | 48.93%165.18M | 49.44%168.2M | -13.32%103.29M |
Lease liabilities | 101.57%616.42M | -32.80%244.18M | -41.22%245.3M | -25.35%289.05M | -23.09%305.8M | -24.51%363.34M | -11.16%417.34M | -24.08%387.2M | -5.91%397.63M | 26.57%481.33M |
Other non current liabilities | 69.92%211.95M | 135.73%171.63M | 87.98%138.19M | --124.49M | --124.74M | --72.81M | -92.65%73.51M | --0 | --0 | --0 |
Total non current liabilities | -4.47%23.79B | -7.65%23.68B | -4.10%24.45B | -12.71%24.61B | -15.79%24.9B | -18.39%25.64B | -27.00%25.5B | -16.80%28.19B | -15.84%29.57B | -2.75%31.42B |
Total liabilities | -3.00%81.85B | -4.43%86.27B | -5.60%84.38B | -5.38%85.84B | -5.62%84.38B | -1.27%90.27B | -5.38%89.38B | -2.74%90.72B | -1.45%89.41B | 9.74%91.43B |
Shareholders equity | ||||||||||
Paid-in capital | -0.05%3.89B | -0.14%3.89B | -0.10%3.9B | -0.10%3.9B | -0.10%3.9B | 0.23%3.9B | 0.25%3.9B | 0.25%3.9B | 0.25%3.9B | 0.20%3.89B |
Other equity instruments | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
-Equity of prefer stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
-Equity of Perpetual debt | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Capital reserve funds | -0.43%8.63B | -0.89%8.63B | -0.72%8.65B | -0.07%8.68B | -6.50%8.67B | -6.24%8.71B | -6.53%8.72B | -6.77%8.69B | -1.45%9.27B | -11.84%9.29B |
Surplus reserve funds | 5.15%2.49B | 0.21%2.37B | 0.21%2.37B | 0.21%2.37B | 0.21%2.37B | 13.21%2.37B | 13.21%2.37B | 13.21%2.37B | 13.21%2.37B | 10.91%2.09B |
Retained profit | -4.86%19.45B | 0.99%20.86B | 0.93%20.84B | 1.72%20.62B | 3.28%20.44B | 18.97%20.66B | 19.97%20.65B | 11.71%20.27B | 11.55%19.79B | 8.87%17.36B |
Less:Treasury stock | 20.76%164.65M | -22.18%223.68M | -46.19%167.8M | -46.19%167.8M | -56.28%136.35M | 10.92%287.45M | 20.34%311.87M | 53.86%311.87M | 338.01%311.87M | 250.00%259.16M |
Other composite income | 14.46%1.24B | -10.81%900.2M | 10.32%1.11B | -1.91%1.08B | 1.58%1.09B | -41.39%1.01B | -19.14%1.01B | -9.64%1.1B | -13.36%1.07B | 52.35%1.72B |
Ordinary risk reserve funds | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Specific reserves | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Shareholders equity without minority interests | -2.15%35.55B | 0.22%36.44B | 1.05%36.71B | 1.30%36.48B | 0.67%36.33B | 6.62%36.35B | 8.42%36.33B | 4.51%36.01B | 5.23%36.09B | 2.37%34.1B |
Minority interests | -1.14%3.29B | -11.82%3.16B | -11.31%3.23B | -14.98%3.34B | -15.29%3.33B | -55.75%3.59B | -50.88%3.65B | -48.11%3.92B | -47.48%3.93B | 19.80%8.11B |
Total shareholder equity | -2.07%38.84B | -0.86%39.6B | -0.08%39.95B | -0.30%39.81B | -0.90%39.66B | -5.36%39.94B | -2.33%39.98B | -4.96%39.94B | -4.22%40.02B | 5.31%42.21B |
Total liabilityies and equity | -2.70%120.69B | -3.33%125.87B | -3.90%124.32B | -3.83%125.65B | -4.16%124.04B | -2.56%130.21B | -4.46%129.36B | -3.43%130.65B | -2.32%129.43B | 8.30%133.63B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
Auditor | Shanghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Shanghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Shanghui Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.